US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist
  • 25.640
  • -0.890-3.35%
Close Mar 28 16:00 ET
  • 25.640
  • 0.0000.00%
Post 16:05 ET
706.20MMarket Cap-10.96P/E (TTM)

LENZ Therapeutics Key Stats

LENZ Therapeutics Q4 2024 Earnings Date

Currency:USDMar 19, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.41
-0.46
-0.05
Miss Est.
--
+50.42%
-11.33%
Net Income
--
-12.65M
--
+46.60%
Strong Buy

Mar 21, 2025

LENZ Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
Mar 19, 20252024/Q40.000 / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
Mar 19, 20252024/Q40.000 / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

LENZ Therapeutics Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 21, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data